Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, September 16 at 2:00 PM EDT

Register Free →

This Government Contract opportunity from Department Of Health And Human Services was posted on June 8, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Data Management and Coding Book Development

Closed
Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 518210
New
SLED
CORES Responder Management System (RMS), EMResource Per Capita and EMResource Dialysis
Solicitation # HHS0017688
The Texas Health and Human Services Commission (HHSC) is issuing an Invitation for Bids (IFB No. HHS0017688) to establish contracts for the renewal of the CORES Responder Management System (RMS), EMResource Per Capita, and EMResource Dialysis. These web-based tools, developed by Juvare, are used by government agencies and healthcare providers to monitor and notify changes in resource status, such as diversions. This is a proprietary purchase under Texas Government Code 2155.067, meaning only bids that conform exactly to the specified brand, make, and model will be considered. The contract is expected to begin upon the date of award and expire on August 31, 2027, with a historical annual spend guideline of approximately 734,822.87 dollars. The award will be based on the best value to the State of Texas, evaluating the bidder's ability to meet specifications, performance delivery, and price. Key requirements include a four-hour response time for service calls and the provision of services during standard business hours, Monday through Friday. Bidders must submit their responses by September 24, 2026, via the HHS Online Bid Room, email, or physical USB delivery. Selected contractors must adhere to strict personnel standards, including comprehensive background checks and E-Verify employment eligibility, and maintain significant insurance coverages, including professional liability and commercial general liability of at least 1 million dollars.
Department of State Health Services

POSTED

1 day ago

DEADLINE

in 13 days

AI Contract Overview

Show more

The contract involves developing and maintaining a secure data management system tailored for de-identified clinical data. Key deliverables include a finalized coding book, rigorous data validation processes, and adherence to an FDA-approved data management plan, ensuring compliance and data integrity throughout the project. This effort supports clinical research data handling with a focus on security and regulatory standards. Scheduled as a subcontract under the NAICS code 518210, the work will be performed in Silver Spring and is overseen by the FDA Office of Acquisition and Grant Services within the Department of Health and Human Services. The solicitation was posted on June 8, 2026, with a response deadline of July 6, 2026, emphasizing a timely and collaborative approach to secure and efficient management of clinical data assets for regulatory and research purposes.

General Info

Develop and maintain secure, FDA-compliant clinical data system with coding book and validation.

Agency

Department Of Health And Human Services → FDA Office Of Acq Grant SvcsView Agency

NAICS

518210 - Computing Infrastructure Providers, Data Processing, Web Hosting, and Related ServicesView NAICS

Place of Performance

Silver Spring, MD, 20993, USA

Set-Aside

NONE

Documents

This scope was carved out of 75F40126R00031.

The full solicitation package (2 documents), including the RFP, is on the prime solicitation, not on this scope.

View the prime solicitation

Investigating Associations Between Acute Abuse Liability Outcomes and Switching Behavior

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

PhaseClosed
Posted

subcontract

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services → FDA Office Of Acq Grant Svcs
ContactsNo contacts available
OfficeN/A
Organization / Agency
Department Of Health And Human Services → FDA Office Of Acq Grant Svcs
View Agency Profile
Office AddressN/A
ContactsNo contact information available

Full Description

Show more
Develop and maintain a secure data management system, including a finalized coding book, data validation, and FDA-approved data management plan for de-identified clinical data.

More opportunities from Department Of Health And Human Services → FDA Office Of Acq Grant Svcs

Same awarding agency

NAICS: 541714
New
Federal
Human Hindbrain Organoid Functional Assay Services.
Solicitation # RFQ_CDR-2026-135968
The U.S. Food and Drug Administration's Center for Drug Evaluation and Research intends to award a sole-source, firm-fixed-price purchase order to OrganoTherapeutics SARL for human induced pluripotent stem cell (iPSC)-derived hindbrain organoid functional assay services. The project aims to support in vitro research evaluating drug-induced effects on respiratory-relevant neural circuits over an eighteen-month period of performance. The scope of work is divided into two primary components: the provision of human hindbrain organoids and associated culture materials through twelve scheduled deliveries to the FDA White Oak Campus, and the performance of functional characterization services at the contractor's laboratory. Functional characterization will utilize three-dimensional multi-electrode array (3D MEA) technology to assess electrophysiological responses to FDA-identified drug and reversal-agent combinations. Deliverables include the delivery of 96 organoids in the first shipment followed by 48 organoids in subsequent deliveries, as well as raw data, analyzed data, analysis files, and comprehensive study reports. This acquisition is conducted as a commercial service under FAR Part 12, with the government restricting competition based on market research identifying OrganoTherapeutics SARL as the only source capable of meeting the complete requirement for both the specific organoid products and the associated functional assay services.
Research and Development in Biotechnology (except Nanobiotechnology)

POSTED

about 12 hours ago

DEADLINE

in 6 days
View Details

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 650+ contractors already using CLEATUS